Your browser doesn't support javascript.
loading
TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors.
Passaia, Barbara Dos Santos; Dias, Matheus Henrique; Kremer, Jean Lucas; Antonini, Sonir Roberto Rauber; de Almeida, Madson Queiroz; Fragoso, Maria Candida Barisson Villares; Lotfi, Claudimara Ferini Pacicco.
Afiliação
  • Passaia BDS; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.
  • Dias MH; Special Laboratory of Applied Toxicology (LETA), Butantan Institute, São Paulo, Brazil.
  • Kremer JL; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.
  • Antonini SRR; Department of Pediatrics and Puericulture, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
  • de Almeida MQ; Adrenal Unit, Hormone and Molecular Genetic Laboratory/LIM42, Hospital of Clinics, School of Medicine, University of São Paulo, São Paulo, Brazil.
  • Fragoso MCBV; Adrenal Unit, Hormone and Molecular Genetic Laboratory/LIM42, Hospital of Clinics, School of Medicine, University of São Paulo, São Paulo, Brazil.
  • Lotfi CFP; Department of Anatomy, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil.
Article em En | MEDLINE | ID: mdl-29520253

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil